Stock Price Forecast

May 28, 2020


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Zafgen, Inc. chart...

About the Company

Zafgen, Inc. is a biopharmaceutical company, which engages in the development of novel therapies for patients affected by complex metabolic diseases. It focuses on the study of MetAP2 inhibitors in both common and rare metabolic disorders. The firm also advancing programs for type 2 diabetes, Prader-Willi syndrome, and liver diseases. The company was founded on November 22, 2005 and is headquartered in Boston, MA.

Sector

Health Technology

Industry

Biotechnology

Employees

7

CEO

Jeffrey S. Hatfield

Exchange

NASDAQ

Website

http://www.zafgen.com

$M

Total Revenue

7

Employees

$37M

Market Capitalization

-1.02

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $ZFGN News

Xeno Biosciences Announces New CEO and Financing

1mon ago, source: Business Wire

Dr. Kim served in a variety of senior executive positions in the industry, most recently as Chief Medical Officer at CymaBay, Emerald Biosciences, and Zafgen, Inc., as well as at Orexigen ...

Optimistic Buy Rating for Larimar Therapeutics Backed by Positive Phase 2 Results and Strategic FDA Discussions

4d ago, source:

Larimar Therapeutics (LRMR – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst on May 10. Analyst ...

Buy Rating for Larimar Therapeutics Backed by Strong Clinical and Financial Outlook

8d ago, source:

Analyst Jonathan Wolleben from JMP Securities reiterated a Buy rating on Larimar Therapeutics (LRMR – Research Report) and keeping the ...

Kevin P Starr's Net Worth

7d ago, source: Benzinga.com

Inc., ZAFGEN, INC., Allena Pharmaceuticals, Inc., and HUMAN GENOME SCIENCES INC. Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the ...

Larimar Therapeutics Inc (LRMR)

9d ago, source: Investing

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...

Lilly's Once-Weekly Insulin Top-Line Results Show Benefit

2d ago, source: Medscape

Merck & Co., Inc.; Novo Nordisk; Omada Health; OptumHealth; Sanofi; and Zafgen. She received research support from Dexcom, ...

About Inc.com | Everything You Need to Know to Grow and Start Your Business

12y ago, source: Inc

Inc. is the voice of the American entrepreneur. We inspire, inform, and document the most fascinating people in business: the risk-takers, the innovators, and the ultra-driven go-getters that ...

Larimar Therapeutics Inc (LRMR)

29d ago, source: Investing

View the LRMR option chain and compare options of Larimar Therapeutics Inc stock. Analyze the various options available, including call options (the right to buy) and put options (the right to ...

LRMR Larimar Therapeutics, Inc.

22d ago, source: Seeking Alpha

Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead ...

LRMR Larimar Therapeutics, Inc.

1y ago, source: Seeking Alpha

Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...